National Vision (EYE) Competitors $11.70 -0.67 (-5.42%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$11.70 +0.01 (+0.04%) As of 02/21/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends EYE vs. NVST, PRCT, IRTC, WRBY, LIVN, ENOV, NVCR, TMDX, LMAT, and TNDMShould you be buying National Vision stock or one of its competitors? The main competitors of National Vision include Envista (NVST), PROCEPT BioRobotics (PRCT), iRhythm Technologies (IRTC), Warby Parker (WRBY), LivaNova (LIVN), Enovis (ENOV), NovoCure (NVCR), TransMedics Group (TMDX), LeMaitre Vascular (LMAT), and Tandem Diabetes Care (TNDM). These companies are all part of the "medical equipment" industry. National Vision vs. Envista PROCEPT BioRobotics iRhythm Technologies Warby Parker LivaNova Enovis NovoCure TransMedics Group LeMaitre Vascular Tandem Diabetes Care Envista (NYSE:NVST) and National Vision (NASDAQ:EYE) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends, media sentiment, valuation and community ranking. Do analysts rate NVST or EYE? Envista presently has a consensus price target of $20.21, indicating a potential downside of 3.33%. National Vision has a consensus price target of $13.40, indicating a potential upside of 14.53%. Given National Vision's stronger consensus rating and higher possible upside, analysts plainly believe National Vision is more favorable than Envista.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Envista 2 Sell rating(s) 9 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.07National Vision 0 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.20 Does the MarketBeat Community prefer NVST or EYE? National Vision received 220 more outperform votes than Envista when rated by MarketBeat users. Likewise, 65.30% of users gave National Vision an outperform vote while only 35.79% of users gave Envista an outperform vote. CompanyUnderperformOutperformEnvistaOutperform Votes3435.79% Underperform Votes6164.21% National VisionOutperform Votes25465.30% Underperform Votes13534.70% Which has more volatility & risk, NVST or EYE? Envista has a beta of 1.34, indicating that its stock price is 34% more volatile than the S&P 500. Comparatively, National Vision has a beta of 1.44, indicating that its stock price is 44% more volatile than the S&P 500. Is NVST or EYE more profitable? National Vision has a net margin of -0.81% compared to Envista's net margin of -44.56%. Envista's return on equity of 3.86% beat National Vision's return on equity.Company Net Margins Return on Equity Return on Assets Envista-44.56% 3.86% 2.21% National Vision -0.81%3.52%1.39% Does the media refer more to NVST or EYE? In the previous week, Envista and Envista both had 4 articles in the media. Envista's average media sentiment score of 1.11 beat National Vision's score of 1.06 indicating that Envista is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Envista 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive National Vision 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable valuation & earnings, NVST or EYE? National Vision has lower revenue, but higher earnings than Envista. National Vision is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnvista$2.51B1.43-$1.12B-$6.49-3.22National Vision$2.13B0.43-$65.90M-$0.20-58.50 SummaryNational Vision beats Envista on 8 of the 15 factors compared between the two stocks. Get National Vision News Delivered to You Automatically Sign up to receive the latest news and ratings for EYE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EYE vs. The Competition Export to ExcelMetricNational VisionOphthalmic goods IndustryStaples SectorNASDAQ ExchangeMarket Cap$921.38M$11.14B$17.03B$8.95BDividend YieldN/A1.63%2.90%3.85%P/E Ratio-58.5036.1116.3118.81Price / Sales0.434.753.8376.66Price / Cash7.0414.6716.7237.47Price / Book1.103.046.914.64Net Income-$65.90M$230.61M$734.56M$245.69M7 Day Performance-5.87%-1.61%-0.34%-2.64%1 Month Performance2.18%-8.13%0.21%-2.37%1 Year Performance-41.76%-11.60%10.04%13.63% National Vision Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EYENational Vision2.3726 of 5 stars$11.70-5.4%$13.40+14.5%-41.8%$921.38M$2.13B-58.5013,998Positive NewsNVSTEnvista3.544 of 5 stars$21.59+0.3%$20.21-6.4%-6.5%$3.71B$2.51B-3.3312,800PRCTPROCEPT BioRobotics3.2668 of 5 stars$67.61-2.4%$97.86+44.7%+28.3%$3.53B$199.84M-34.67430Positive NewsIRTCiRhythm Technologies1.1354 of 5 stars$112.11-0.1%$108.45-3.3%+6.8%$3.51B$492.68M-23.072,000Earnings ReportAnalyst ForecastNews CoverageGap UpWRBYWarby Parker2.5425 of 5 stars$25.70-2.7%$21.77-15.3%+71.6%$2.61B$669.77M-95.193,491Upcoming EarningsAnalyst ForecastLIVNLivaNova3.5803 of 5 stars$47.68+0.1%$69.17+45.1%-16.5%$2.59B$1.15B113.522,900Upcoming EarningsENOVEnovis3.4615 of 5 stars$43.89+0.4%$64.83+47.7%-29.1%$2.50B$1.71B-20.046,550Short Interest ↓Positive NewsNVCRNovoCure3.4804 of 5 stars$22.48+3.5%$32.67+45.3%+41.4%$2.43B$509.34M-16.061,453Upcoming EarningsNews CoverageTMDXTransMedics Group3.6152 of 5 stars$72.18+1.3%$122.70+70.0%-17.3%$2.42B$241.62M76.79210News CoverageGap UpLMATLeMaitre Vascular1.9524 of 5 stars$98.65+1.7%$94.63-4.1%+59.9%$2.22B$193.48M53.91490TNDMTandem Diabetes Care4.0868 of 5 stars$33.47+2.6%$53.81+60.8%+37.5%$2.20B$747.72M-17.342,400Positive News Related Companies and Tools Related Companies NVST Alternatives PRCT Alternatives IRTC Alternatives WRBY Alternatives LIVN Alternatives ENOV Alternatives NVCR Alternatives TMDX Alternatives LMAT Alternatives TNDM Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:EYE) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding National Vision Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share National Vision With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.